Private Equity

Dr. Glenn Parker's recent award is more than a trophy. It's a signal of a quiet revolution in healthcare—one that uses fintech to build national resilience.

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

A DoW contract for in-orbit refueling thrusts Quantum Space into the spotlight, promising to redefine space warfare and ignite the orbital logistics economy.

Verite Capital Partners appoints biodiesel pioneer Sumit Majumdar as CSO, leveraging $27B in capital to create 1M green jobs and cut global emissions.

With a fresh $260M, Dream is building AI for nations to own. But as governments rush for digital autonomy, are we creating a new digital iron curtain?

A new study reveals Canadians will pay $94.4 billion in debt interest this year, diverting funds from healthcare, education, and future growth.

After a 20-year drought, positive Phase 3 data for oral olorofim signals a safer, potent new option against a deadly fungus, promising a major market shake-up.

With 2.25M developers and advanced hybrid cloud adoption, India isn't just joining the cloud native world; it's rewriting the rules for global innovation.

Amid a resurgent SPAC market, Wilco 63 launches a $200M hunt for a tech unicorn in AI and robotics. Can it navigate a landscape that now values execution over hype?

Netlist's new patent lawsuits over HBM and DDR5 memory could disrupt the AI supply chain, putting the tech giants' critical components in legal peril.

With a $150M war chest, E. Scott Crist's latest SPAC hunts for an industrial tech gem. But can a team with a mixed track record deliver in this new era?

Office Properties Income Trust emerges from bankruptcy with $714M less debt and new owners. Is its strategic overhaul a model for a sector in crisis?

abrdn's Asia-Pacific Income Fund (FAP) just boosted its monthly distribution by 14%. We deconstruct what this means for income investors amid market complexities.

Keyera's full acquisition of the KAPS pipeline isn't just a transaction; it's a strategic consolidation that signals deep confidence in Western Canada's energy future.

An insurance giant's bet on an AI governance startup reveals a hidden truth: as AI takes over, the race is on to control it before it controls us.

As RESTEM presents at BIO 2026, the company showcases its novel cell therapies aiming to reprogram the immune system, not just manage symptoms.

Vultr is making a bold play, leveraging HPE and NVIDIA's latest tech to build a global, decentralized AI network challenging the dominance of cloud giants.

With a $300M+ war chest, Adam Goodman's 'tradigital' studio aims to merge YouTube virality with Hollywood's franchise-building machine.

Thoreau's major investment in Ensemble signals a tech-fueled future for healthcare RCM, aiming to slash costs and boost efficiency with advanced AI.

As AI agents take on enterprise work, how can we trust their data? Docugami and Inveniam offer a solution combining document intelligence and blockchain.